The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $87.72

Today's change-0.57 -0.65%
Updated September 27 12:24 PM EDT. Delayed by at least 15 minutes.
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $87.72

Today's change-0.57 -0.65%
Updated September 27 12:24 PM EDT. Delayed by at least 15 minutes.

Vertex Pharmaceuticals Inc down (U.S.)$0.57

Vertex Pharmaceuticals Inc is lower today, dropping (U.S.)$0.57 or 0.65% to (U.S.)$87.72. Over the last five days, shares have lost 4.33% and are down 30.29% for the last year to date. This security has underperformed the S&P 500 by 26.88% during the last year.

Key company metrics

  • Open(U.S.) $88.23
  • Previous close(U.S.) $88.29
  • High(U.S.) $88.66
  • Low(U.S.) $87.25
  • Bid / Ask(U.S.) $87.63 / (U.S.) $87.72
  • YTD % change-30.29%
  • Volume595,653
  • Average volume (10-day)1,870,521
  • Average volume (1-month)1,261,144
  • Average volume (3-month)1,395,319
  • 52-week range(U.S.) $75.90 to (U.S.) $134.71
  • Beta0.47
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward88.66×
  • Forward PEG1.66×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.13
Updated September 27 12:24 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue432398418310
Total other revenue--------
Total revenue432398418310
Gross profit387348356280
Total cost of revenue44506230
Total operating expense428412472380
Selling / general / administrative11210597100
Research & development271256310246
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0122
Other operating expenses, total1112
Operating income3-14-54-70
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-18-31-76-92
Income after tax-36-36-75-94
Income tax, total185-11
Net income-65-42-74-95
Total adjustments to net income--------
Net income before extra. items-65-42-74-95
Minority interest-28-61-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-65-42-74-95
Inc. avail. to common incl. extra. items-65-42-74-95
Diluted net income-65-42-74-95
Dilution adjustment--------
Diluted weighted average shares244244243242
Diluted EPS excluding extraordinary itemsvalue per share-0.26-0.17-0.30-0.39
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.26-0.17-0.30-0.39